Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030

icon1
USD 21.59 BN
MARKET SIZE, 2030
icon2
CAGR 6.4%
(2025-2030)
icon3
300
REPORT PAGES
icon4
230
MARKET TABLES

OVERVIEW

Biosurgery Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The biosurgery market is projected to reach USD 21.59 billion by 2030 from USD 15.83 billion in 2025, at a CAGR of 6.4% from 2025 to 2030. The growth of the biosurgery market is driven by rising focus towards effective blood loss management and growth in the volume of elective surgeries.

KEY TAKEAWAYS

  • BY TYPE
    The biosurgery market comprises Bone Graft Substitutes, Soft-tissue attachments, Hemostatic agents, Surgical sealants and adhesives, Adhesion Barriers, and Staple-Line Reinforcement Agents. The bone-graft substitute segment holds the major share in the biosurgery market due to its growing adoption in orthopedic and dental procedures, coupled with its distinct clinical and logistical advantages over traditional autografts
  • BY APPLICATION
    Key applications of the biosurgery market are Orthopaedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynaecological Surgery, Urological Surgery, Thoracic Surgery, and Others. The reconstructive surgery segment is anticipated to be the fastest-growing segment in the biosurgery market during the forecast period, driven by a surge in demand for both medically necessary and elective procedures.
  • BY END-USER
    Key End-user includes Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), and Others. The hospital segment holds the major share in the biosurgery market primarily due to the high volume of complex and minimally invasive surgical procedures conducted in these settings.
  • BY REGION
    The biosurgery market covers North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is the fastest-growing market for biosurgery due to the combination of rapidly expanding healthcare infrastructure, rising surgical procedure volumes, and increasing adoption of advanced surgical technologies.
  • COMPETITIVE LANDSCAPE
    Major market players have adopted both organic and inorganic strategies, including partnerships and investments. For instance, Kuros Biosciences, Orthofix Medical Inc., Zimmer Biomet Holdings, Inc. have entered into a several agreements and partnerships to cater to the growing demand for biosurgery across innovative applications.

The biosurgery market is witnessing steady growth, driven by the Increasing prevalence of lifestyle disorders & chronic diseases, the rising geriatric population, and an increase in elective surgical procedures globally. New deals and developments, including strategic partnerships between OEMs and suppliers, investments in modern technologies, and innovations in customer-focused biosurgery products, are reshaping the industry landscape.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The global biosurgery market is undergoing significant disruption and transformation due to a variety of trends and pressures. Rising surgical volumes, an ageing global population, and increasing rates of chronic diseases are amplifying demand for advanced biosurgical solutions across hospitals and ambulatory surgical centres. At the same time, regulatory challenges, long clinical trial timelines, and complex market access requirements are raising barriers for product innovation and commercialisation. Global supply chain disruptions, shifts in reimbursement strategies, and the push for cost-effective, personalised medicine are reshaping procurement patterns. Digital transformation, including AI-driven surgical planning, 3D imaging, and data-driven R&D, is accelerating the development of minimally invasive, precision-focused biosurgery products. As these disruptions converge, biosurgery stakeholders are focusing on optimising budgets, enhancing clinical outcomes, and rapidly adapting to evolving regulatory and technological landscapes worldwide.

Biosurgery Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing volume of surgeries and growing prevalence of severe trauma injuries
  • Rising need for effective blood loss management in patients
RESTRAINTS
Impact
Level
  • High price of biosurgery products and the rising cost of surgical procedures
OPPORTUNITIES
Impact
Level
  • Growing use of combination materials for enhancing product efficacy
  • Growing adoption of adhesive dentistry procedures
CHALLENGES
Impact
Level
  • Stringent regulatory framework
  • Scarcity of skilled personnel for the effective use of biosurgery products

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising need for effective blood loss management in patients

The rising need for effective blood loss management is a key driver of growth in the global biosurgery market, fueled by increasing trauma cases, complex surgical procedures, and limitations of traditional wound closure methods. The growing surgical burden, combined with the clinical advantages of biosurgery products, continues to drive demand for innovative, efficient blood loss management solutions in the biosurgery market.

Restraint: High price of biosurgery products and the rising cost of surgical procedures

The high price of biosurgery products and the rising cost of surgical procedures are significant factors restraining the growth of the biosurgery market, particularly in cost-sensitive and emerging economies. The rising cost of surgical procedures overall—including labor, equipment, and post-operative care—places additional financial pressure on hospitals and patients, reducing the willingness to adopt premium-priced biosurgery products.

Opportunity: Growing adoption of adhesive dentistry procedures

The growing adoption of advanced biosurgery products in emerging markets presents a significant opportunity for the biosurgery market to expand. Countries across Asia Pacific, Latin America, and the Middle East & Africa, particularly China, India, and Brazil, are witnessing a surge in demand due to a large and growing patient base for conditions such as cardiovascular, orthopaedic, gynaecological, and general/abdominal disorders that require surgical intervention.

Challenge: Stringent regulatory framework

The stringent regulatory framework poses a significant challenge to the growth of the biosurgery market. Developing and commercializing new biosurgery products involves extensive investments in R&D, prolonged development timelines, and navigating complex regulatory pathways.

Biosurgery Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Bone-graft substitutes, surgical sealants & adhesives, adhesion barriers, staple-line reinforcement, soft-tissue attachments, and hemostatic agents for hemostasis, tissue sealing, adhesion prevention, and tissue repair in surgical procedures. Advanced hemostasis, minimized risk of leaks and bleeding, improved tissue handling, and effective adhesion prevention. Ethicon’s powered stapling and energy devices deliver enhanced sealing, less tissue slippage, and optimized surgical recovery.
Biosurgery portfolio includes hemostats and sealants, adhesion barrier for preventing adhesions; and suture line reinforcement and sealing in cardiovascular and general surgery. Rapid surgical hemostasis, effective adhesion reduction, strong, consistent tissue sealing, broad multi-specialty versatility, and clinically proven reduction in postoperative complications and optimized surgical workflow.
Polymeric sealants, biological adhesives, skin and tissue closure products, and staple-line reinforcement agents for wound closure, spinal, cranial, and complex general surgery. Enables rapid, needle-free wound closure, strong adhesion even in high-tension and moist environments, reduced CSF and other fluid leaks, and lower risk of infection. Enables sutureless procedures and improved cosmetic outcomes with robust tissue support.
Synthetic and allograft bone grafts, staple-line reinforcement, soft-tissue attachments, dural sealants, and topical adhesives for craniofacial, spine, orthopaedic, and trauma applications. Excellent osteointegration, reliable watertight dural sealing (99% CSF leak prevention), absorbable biomaterials for long-term regeneration, and reduced need for autograft harvesting all supporting faster healing and complication risk reduction.
Biosurgery portfolio includes hemostatic agents, surgical sealants, absorbable sponges, and soft-tissue reinforcement for bleeding control and tissue closure used in open and minimally invasive surgeries. Accelerates natural clotting, delivers rapid, reliable hemostasis, reduces surgical air leaks, is easy to use even in complex fields, and offers thrombin-free, 100% plant-based and collagen-based options proven safe and effective in a wide range of specialties

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem of the biosurgery market is a multifaceted network comprising various interconnected stakeholders involved across the product lifecycle. At the core of the ecosystem are manufacturers who engage in end-to-end activities including in-house R&D, product formulation, testing, optimization, regulatory compliance, and final product launch. These manufacturers may also collaborate with Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) to enhance development efficiency and reduce time-to-market. Distribution is managed through a combination of third-party distributors and e-commerce platforms, ensuring broad market penetration and availability of products across geographies. End users form a crucial component, comprising hospitals, ambulatory surgical centers, and specialty clinics where biosurgery products are utilized in a wide range of surgical interventions and wound management procedures.

Biosurgery Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Biosurgery Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Biosurgery Market, By Product

Based on products, the biosurgery market is segmented into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants & adhesives, adhesion barriers, and staple-line reinforcement agents. The bone-graft substitute segment holds the major share in the biosurgery market due to its growing adoption in orthopedic and dental procedures, coupled with its distinct clinical and logistical advantages over traditional autografts.

Biosurgery Market, By Application

Based on applications, the biosurgery market is segmented into orthopedic surgeries, general surgeries, neurological surgeries, cardiovascular surgeries, reconstructive surgeries, gynecological surgeries, urological surgeries, thoracic surgeries and other surgeries (that include dental, trauma, ophthalmic and ENT surgeries). The orthopedic segment holds a significant share in the global biosurgery market, primarily driven by the increasing volume of reconstructive and spinal fusion procedures worldwide

Biosurgery Market, By End-user

Based on end users, the Biosurgery market is bifurcated into ambulatory surgical centres, hospitals, Clinics, and Other End Users. The hospital segment accounted for the major share in the market. The hospital segment holds the major share in the biosurgery market primarily due to the high volume of complex and minimally invasive surgical procedures conducted in these settings.

REGION

Asia Pacific to be fastest-growing region in global biosurgery market during forecast period

During forecast period, Asia Pacific is the fastest-growing regional market for biosurgery devices. This is due to the combination of rapidly expanding healthcare infrastructure, rising surgical procedure volumes, and increasing adoption of advanced surgical technologies. Countries like China, India, and Japan are witnessing a significant rise in inpatient surgeries and cosmetic procedures. The influx of medical tourism, particularly in countries like India, Thailand, and Malaysia, is also boosting the adoption of high-quality biosurgery products, making Asia Pacific the fastest-growing regional market.

Biosurgery Market Region

Biosurgery Market: COMPANY EVALUATION MATRIX

In the biosurgery market matrix, Johnson & Johnson (US) (Star) leads with scale, extensive distribution, and a broad product portfolio. Integra LifeSciences Holdings Corporation (US) (Emerging Leader) is gaining momentum with variety of biosurgery products. Kuros Biosciences AG (Switzerland), stand out as well-established companies with effective business strategies. Globus Medical, Inc. (US) potential to build a strong product portfolio and business strategy to compete in the market.

Biosurgery Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 14.95 Billion
Market Forecast in 2030 (value) USD 21.59 Billion
Growth Rate CAGR of 6.4% from 2025-2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion), Volume (Kiloton)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends.
Segments Covered
  • By Type:
    • bone-graft substitutes
    • soft-tissue attachments
    • hemostatic agents
    • surgical sealants & adhesives
    • adhesion barriers
    • staple-line reinforcement agents
  • By Application:
    • orthopaedic surgeries
    • general surgeries
    • neurological surgeries
    • cardiovascular surgeries
    • reconstructive surgeries
    • gynaecological surgeries
    • urological surgeries
    • thoracic surgeries other surgeries
  • By End-user:
    • Hospitals
    • Clinics
    • ambulatory surgical centres
    • Other End Users
Regions Covered North America, Asia Pacific, Europe, South America, Middle East & Africa

WHAT IS IN IT FOR YOU: Biosurgery Market REPORT CONTENT GUIDE

Biosurgery Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Comparison of key Biosurgery products: bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants & adhesives, adhesion barriers, and staple-line reinforcement agents Identify interconnections and supply chain blind spots; Detect customer migration trends across industries
Company Information
  • Key players: Baxter International Inc. (US), B. Braun SE (Germany), Becton Dickinson and Company (US), Johnson & Johnson (US), Medtronic plc (Ireland), and Stryker Corporation (US)
  • Top 3-5 players market share analysis at the APAC and European country level.
Insights on revenue shifts towards emerging therapeutic applications and device innovations
Geographic Analysis
  • A detailed analysis of the Rest of APAC was provided to one of the top players
  • Client focused on ASEAN Market country-level analysis for the device market.
Country-level demand mapping for new product launches and localization strategy planning

RECENT DEVELOPMENTS

  • January 2025 : Kuros Biosciences USA, Inc. has entered into an exclusive strategic agreement with Medtronic’s Spinal Division, appointing Medtronic as the exclusive sales agent for MagnetOs in designated territories for spinal surgery applications
  • January 2024 : Kuros Biosciences has received U.S. FDA 510(k) clearance for the use of MagnetOs Granules in interbody spinal procedures, along with regulatory approval for MagnetOs Granules and MagnetOs Putty in New Zealand.
  • January 2023 : Zimmer Biomet Holdings, Inc. announced that it has entered into a definitive agreement to acquire Embody, Inc., a company specializing in soft tissue healing, for USD 155 million at closing, with up to an additional USD 120 million contingent upon the achievement of future regulatory and commercial milestones over a three-year period.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
36
2
RESEARCH METHODOLOGY
 
 
 
42
3
EXECUTIVE SUMMARY
 
 
 
55
4
PREMIUM INSIGHTS
 
 
 
59
5
MARKET OVERVIEW
Surging demand for advanced biosurgery solutions amid rising surgeries and innovative adhesive technologies.
 
 
 
63
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
INCREASING VOLUME OF SURGERIES AND GROWING PREVALENCE OF SEVERE TRAUMA INJURIES
 
 
 
 
5.2.1.2
RISING NEED FOR EFFECTIVE BLOOD LOSS MANAGEMENT
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH PRICE OF BIOSURGERY PRODUCTS AND SURGICAL PROCEDURES
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
RISING USE OF COMBINATION MATERIALS FOR ENHANCING PRODUCT EFFICACY
 
 
 
 
5.2.3.2
GROWING ADOPTION OF ADHESIVE DENTISTRY PROCEDURES
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
STRINGENT REGULATORY FRAMEWORK
 
 
 
 
5.2.4.2
SCARCITY OF SKILLED PERSONNEL FOR EFFECTIVE USE OF BIOSURGERY PRODUCTS
 
 
5.3
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.3.1
KEY TECHNOLOGIES
 
 
 
 
 
5.3.1.1
HEMOSTATIC & SEALANT BIOMATERIAL TECHNOLOGY
 
 
 
 
5.3.1.2
TISSUE ENGINEERING & REGENERATIVE MEDICINE TECHNOLOGY
 
 
 
5.3.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.3.2.1
SURGICAL IMAGING & NAVIGATION TECHNOLOGY
 
 
 
 
5.3.2.2
STERILIZATION & PRESERVATION TECHNOLOGY
 
 
 
5.3.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.3.3.1
3D PRINTING TECHNOLOGY
 
 
 
 
5.3.3.2
MINIMALLY INVASIVE TECHNOLOGY
 
 
5.4
INDUSTRY TRENDS
 
 
 
 
 
5.4.1
GROWING PREFERENCE FOR GELATIN-BASED ADHESIVES & HYDROGELS IN SURGICAL PROCEDURES
 
 
 
 
5.4.2
USE OF NANOTECHNOLOGY FOR DEVELOPING NEXT-GENERATION ADHESIVES
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.6
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.7
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.8
TRADE ANALYSIS
 
 
 
 
 
 
5.8.1
IMPORT DATA FOR HS CODE 300610, 2019–2024
 
 
 
 
5.8.2
EXPORT DATA FOR HS CODE 300610, 2019–2024
 
 
 
5.9
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.9.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.9.2
THREAT OF SUBSTITUTES
 
 
 
 
5.9.3
BARGAINING POWER OF BUYERS
 
 
 
 
5.9.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.9.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.10
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.10.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.10.2
KEY BUYING CRITERIA
 
 
 
5.11
REGULATORY ANALYSIS
 
 
 
 
 
5.11.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
5.11.2
REGULATORY ANALYSIS
 
 
 
 
 
5.11.2.1
NORTH AMERICA
 
 
 
 
5.11.2.2
EUROPE
 
 
 
 
5.11.2.3
ASIA PACIFIC
 
 
 
 
5.11.2.4
LATIN AMERICA
 
 
 
 
5.11.2.5
MIDDLE EAST & AFRICA
 
 
5.12
PATENT ANALYSIS
 
 
 
 
 
 
5.12.1
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
 
 
 
5.13
PRICING ANALYSIS
 
 
 
 
 
 
5.13.1
AVERAGE SELLING PRICE TREND OF BIOSURGERY PRODUCTS, BY KEY PLAYER, 2022–2024
 
 
 
 
5.13.2
AVERAGE SELLING PRICE TREND OF BIOSURGERY PRODUCTS, BY REGION, 2022–2024
 
 
 
5.14
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.15
ADJACENT MARKET ANALYSIS
 
 
 
 
 
5.15.1
ADHESION BARRIERS MARKET
 
 
 
5.16
UNMET NEEDS/END-USER EXPECTATIONS
 
 
 
 
5.17
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
5.18
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
5.19
IMPACT OF AI/GEN AI ON BIOSURGERY MARKET
 
 
 
 
 
5.20
IMPACT OF 2025 US TARIFF ON BIOSURGERY MARKET
 
 
 
 
 
 
5.20.1
INTRODUCTION
 
 
 
 
5.20.2
KEY TARIFF RATES
 
 
 
 
5.20.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.20.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
5.20.4.1
NORTH AMERICA
 
 
 
 
5.20.4.2
EUROPE
 
 
 
 
5.20.4.3
ASIA PACIFIC
 
 
 
5.20.5
IMPACT ON END-USE INDUSTRIES
 
 
6
BIOSURGERY MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 70 Data Tables
 
 
 
95
 
6.1
INTRODUCTION
 
 
 
 
6.2
BONE-GRAFT SUBSTITUTES
 
 
 
 
 
6.2.1
DEMINERALIZED BONE MATRIX
 
 
 
 
 
6.2.1.1
RISING VOLUME OF SPINAL FUSION, JOINT RECONSTRUCTION, AND REPLACEMENT SURGERIES TO DRIVE SEGMENT
 
 
 
6.2.2
SYNTHETIC BONE GRAFTS
 
 
 
 
 
6.2.2.1
HIGH COMPRESSIVE STRENGTH, OSTEOCONDUCTIVE PROPERTIES, AND MINIMAL RISK OF DISEASE TRANSMISSION TO FUEL SEGMENT GROWTH
 
 
 
6.2.3
BONE MORPHOGENETIC PROTEINS
 
 
 
 
 
6.2.3.1
INCREASING PREVALENCE OF SPINAL DEFORMITIES, DISC DEGENERATION, TRAUMA, AND SPORT-RELATED INJURIES TO PROPEL SEGMENT GROWTH
 
 
 
6.2.4
OTHER BONE-GRAFT SUBSTITUTES
 
 
 
6.3
SURGICAL SEALANTS & ADHESIVES
 
 
 
 
 
6.3.1
NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES
 
 
 
 
 
6.3.1.1
NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES, BY TYPE
 
 
 
 
6.3.1.2
NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES, BY ORIGIN
 
 
 
6.3.2
SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES
 
 
 
 
 
6.3.2.1
PEG HYDROGEL-BASED SEALANTS & ADHESIVES
 
 
 
 
6.3.2.2
CYANOACRYLATE-BASED SEALANTS & ADHESIVES
 
 
 
 
6.3.2.3
URETHANE-BASED SEALANTS & ADHESIVES
 
 
 
 
6.3.2.4
OTHER SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES
 
 
6.4
ADHESION BARRIERS
 
 
 
 
 
6.4.1
SYNTHETIC ADHESION BARRIERS
 
 
 
 
 
6.4.1.1
HYALURONIC ACID-BASED ADHESION BARRIERS
 
 
 
 
6.4.1.2
REGENERATED CELLULOSE-BASED ADHESION BARRIERS
 
 
 
 
6.4.1.3
PEG-BASED ADHESION BARRIERS
 
 
 
 
6.4.1.4
OTHER SYNTHETIC ADHESION BARRIERS
 
 
 
6.4.2
NATURAL ADHESION BARRIERS
 
 
 
 
 
6.4.2.1
COLLAGEN & PROTEIN ADHESION BARRIERS
 
 
 
 
6.4.2.2
FIBRIN-BASED ADHESION BARRIERS
 
 
6.5
STAPLE-LINE REINFORCEMENT AGENTS
 
 
 
 
 
6.5.1
RISING VOLUME OF COMPLEX SURGICAL PROCEDURRES TO DRIVE MARKET
 
 
 
6.6
SOFT-TISSUE ATTACHMENTS
 
 
 
 
 
6.6.1
SYNTHETIC MESHES
 
 
 
 
 
6.6.1.1
INCREASING DEMAND FOR SAFE AND COST-EFFECTIVE SOFT TISSUE REINFORCEMENT TO DRIVE SEGMENT
 
 
 
6.6.2
BIOLOGICAL MESHES
 
 
 
 
 
6.6.2.1
ALLOGRAFTS
 
 
 
 
6.6.2.2
XENOGRAFTS
 
 
6.7
HEMOSTATIC AGENTS
 
 
 
 
 
6.7.1
THROMBIN-BASED HEMOSTATIC AGENTS
 
 
 
 
 
6.7.1.1
RISING DEMAND FOR SAFER AND FAST-ACTING CLOTTING AGENTS TO DRIVE GROWTH OF THROMBIN-BASED HEMOSTATS
 
 
 
6.7.2
OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS
 
 
 
 
 
6.7.2.1
RISING ADOPTION OF PLANT-BASED AND ABSORBABLE HEMOSTATS TO PROPEL SEGMENT GROWTH
 
 
 
6.7.3
COMBINATION HEMOSTATIC AGENTS
 
 
 
 
 
6.7.3.1
SUPERIOR EFFICACY IN COMPLEX BLEEDING CONTROL TO DRIVE ADOPTION OF COMBINATION HEMOSTATIC AGENTS GLOBALLY
 
7
BIOSURGERY MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
 
 
 
157
 
7.1
INTRODUCTION
 
 
 
 
7.2
ORTHOPEDIC SURGERY
 
 
 
 
 
7.2.1
INCREASING INCIDENCE OF SPORTS INJURIES AND GROWING PREVALENCE OF OSTEOPOROSIS TO PROPEL MARKET GROWTH
 
 
 
7.3
GENERAL SURGERY
 
 
 
 
 
7.3.1
HIGH GERIATRIC POPULATION AND INCREASED PREVALENCE OF OBESITY TO FUEL DEMAND FOR BARIATRIC INTERVENTIONS
 
 
 
7.4
NEUROLOGICAL SURGERY
 
 
 
 
 
7.4.1
GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO AUGMENT MARKET GROWTH
 
 
 
7.5
CARDIOVASCULAR SURGERY
 
 
 
 
 
7.5.1
BIOSURGERY PRODUCTS TO REPLACE CONVENTIONAL SUTURE-BASED METHODS IN CARDIOVASCULAR PROCEDURES
 
 
 
7.6
RECONSTRUCTIVE SURGERY
 
 
 
 
 
7.6.1
INCREASING FACIAL COSMETIC SURGERIES AND BREAST RECONSTRUCTION PROCEDURES TO PROPEL MARKET GROWTH
 
 
 
7.7
GYNECOLOGICAL SURGERY
 
 
 
 
 
7.7.1
COMPLEXITY OF GYNECOLOGICAL PROCEDURES TO FUEL DEMAND FOR ADVANCED BIOSURGICAL PRODUCTS
 
 
 
7.8
UROLOGICAL SURGERY
 
 
 
 
 
7.8.1
USE OF BIOSURGERY PRODUCTS IN COMPLEX RECONSTRUCTIVE UROLOGICAL SURGERIES TO STIMULATE SEGMENT GROWTH
 
 
 
7.9
THORACIC SURGERY
 
 
 
 
 
7.9.1
RISING INCIDENCE OF PULMONARY CHRONIC DISEASES TO SPUR MARKET GROWTH
 
 
 
7.10
OTHER APPLICATIONS
 
 
 
8
BIOSURGERY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 5 Data Tables
 
 
 
173
 
8.1
INTRODUCTION
 
 
 
 
8.2
HOSPITALS
 
 
 
 
 
8.2.1
RISING NUMBER OF REIMBURSED INPATIENT PROCEDURES TO DRIVE POPULARITY OF HOSPITALS FOR SURGERIES
 
 
 
8.3
CLINICS
 
 
 
 
 
8.3.1
QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS TO FAVOR MARKET GROWTH
 
 
 
8.4
AMBULATORY SURGICAL CENTERS
 
 
 
 
 
8.4.1
RISING DEMAND FOR COST-EFFECTIVE SAME-DAY SURGERIES TO AUGMENT MARKET GROWTH
 
 
 
8.5
OTHER END USERS
 
 
 
9
BIOSURGERY MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 342 Data Tables.
 
 
 
180
 
9.1
INTRODUCTION
 
 
 
 
9.2
NORTH AMERICA
 
 
 
 
 
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
9.2.2
US
 
 
 
 
 
9.2.2.1
US TO DOMINATE NORTH AMERICAN BIOSURGERY MARKET DURING FORECAST PERIOD
 
 
 
9.2.3
CANADA
 
 
 
 
 
9.2.3.1
GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
 
 
9.3
EUROPE
 
 
 
 
 
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
9.3.2
GERMANY
 
 
 
 
 
9.3.2.1
ROBUST HEALTHCARE INVESTMENTS AND IMPROVED INFRASTRUCTURE TO SUPPORT ADOPTION OF ADVANCED SURGICAL TECHNOLOGIES
 
 
 
9.3.3
UK
 
 
 
 
 
9.3.3.1
RISE IN POPULARITY OF COSMETIC AND RECONSTRUCTIVE SURGERIES TO FUEL MARKET GROWTH
 
 
 
9.3.4
FRANCE
 
 
 
 
 
9.3.4.1
PRESENCE OF WELL-ESTABLISHED HEALTHCARE SYSTEM AND HIGH GERIATRIC POPULATION TO BOOST MARKET GROWTH
 
 
 
9.3.5
ITALY
 
 
 
 
 
9.3.5.1
INCREASING SURGICAL VOLUME TO FUEL MARKET GROWTH
 
 
 
9.3.6
SPAIN
 
 
 
 
 
9.3.6.1
RISING SURGICAL DEMAND TO BOOST NEED FOR BIOSURGERY PRODUCTS
 
 
 
9.3.7
REST OF EUROPE
 
 
 
9.4
ASIA PACIFIC
 
 
 
 
 
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
9.4.2
CHINA
 
 
 
 
 
9.4.2.1
INCREASING NUMBER OF DOMESTIC BIOSURGERY AND MEDICAL DEVICE MANUFACTURERS TO AID MARKET GROWTH
 
 
 
9.4.3
INDIA
 
 
 
 
 
9.4.3.1
RISING HEALTHCARE AWARENESS AND FAVORABLE GOVERNMENT SUPPORT TO STIMULATE MARKET GROWTH
 
 
 
9.4.4
JAPAN
 
 
 
 
 
9.4.4.1
ADVANCED HEALTHCARE SYSTEM AND HIGH GERIATRIC POPULATION TO SPUR MARKET GROWTH
 
 
 
9.4.5
SOUTH KOREA
 
 
 
 
 
9.4.5.1
RISING NUMBER OF COSMETIC SURGERIES AND GROWING ADOPTION OF INNOVATIVE MEDICAL TECHNOLOGIES TO DRIVE MARKET
 
 
 
9.4.6
AUSTRALIA
 
 
 
 
 
9.4.6.1
WELL-ESTABLISHED HEALTHCARE SYSTEM AND HIGH GOVERNMENT MEDICAL EXPENDITURE TO FAVOR MARKET GROWTH
 
 
 
9.4.7
REST OF ASIA PACIFIC
 
 
 
9.5
LATIN AMERICA
 
 
 
 
 
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
9.5.2
BRAZIL
 
 
 
 
 
9.5.2.1
RAPIDLY AGING POPULATION AND HIGH PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
 
 
 
9.5.3
MEXICO
 
 
 
 
 
9.5.3.1
ENHANCED FOCUS ON MEDICAL TOURISM TO DRIVE MARKET
 
 
 
9.5.4
REST OF LATIN AMERICA
 
 
 
9.6
MIDDLE EAST & AFRICA
 
 
 
 
 
9.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
9.6.2
GCC COUNTRIES
 
 
 
 
 
9.6.2.1
RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
 
 
 
9.6.3
REST OF MIDDLE EAST & AFRICA
 
 
10
COMPETITIVE LANDSCAPE
Discover strategic dominance and emerging leaders shaping the biosurgery market landscape.
 
 
 
332
 
10.1
INTRODUCTION
 
 
 
 
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOSURGERY MARKET
 
 
 
10.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
10.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
10.5.1
STARS
 
 
 
 
10.5.2
EMERGING LEADERS
 
 
 
 
10.5.3
PERVASIVE PLAYERS
 
 
 
 
10.5.4
PARTICIPANTS
 
 
 
 
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
10.5.5.1
COMPANY FOOTPRINT
 
 
 
 
10.5.5.2
REGION FOOTPRINT
 
 
 
 
10.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
10.5.5.4
APPLICATION FOOTPRINT
 
 
 
 
10.5.5.5
END-USER FOOTPRINT
 
 
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
10.6.1
PROGRESSIVE COMPANIES
 
 
 
 
10.6.2
RESPONSIVE COMPANIES
 
 
 
 
10.6.3
DYNAMIC COMPANIES
 
 
 
 
10.6.4
STARTING BLOCKS
 
 
 
 
10.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
10.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
10.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
10.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
10.7.1
FINANCIAL METRICS
 
 
 
 
10.7.2
COMPANY VALUATION
 
 
 
10.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
10.9
COMPETITIVE SCENARIO
 
 
 
 
 
10.9.1
PRODUCT LAUNCHES & APPROVALS
 
 
 
 
10.9.2
DEALS
 
 
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
350
 
11.1
KEY PLAYERS
 
 
 
 
 
11.1.1
BAXTER
 
 
 
 
 
11.1.1.1
BUSINESS OVERVIEW
 
 
 
 
11.1.1.2
PRODUCTS OFFERED
 
 
 
 
11.1.1.3
MNM VIEW
 
 
 
11.1.2
B. BRAUN SE
 
 
 
 
11.1.3
BECTON, DICKINSON AND COMPANY (BD)
 
 
 
 
11.1.4
JOHNSON & JOHNSON
 
 
 
 
11.1.5
MEDTRONIC
 
 
 
 
11.1.6
INTEGRA LIFESCIENCES CORPORATION
 
 
 
 
11.1.7
COMMONWEALTH SERUM LABORATORIES LIMITED (CSL)
 
 
 
 
11.1.8
HEMOSTASIS, LLC
 
 
 
 
11.1.9
PFIZER INC.
 
 
 
 
11.1.10
STRYKER
 
 
 
 
11.1.11
ARTIVION, INC.
 
 
 
 
11.1.12
ZIMMER BIOMET
 
 
 
 
11.1.13
KUROS BIOSCIENCES
 
 
 
 
11.1.14
ORTHOFIX MEDICAL INC.
 
 
 
 
11.1.15
SMITH & NEPHEW
 
 
 
11.2
OTHER PLAYERS
 
 
 
 
 
11.2.1
TISSUE REGENIX
 
 
 
 
11.2.2
BETATECH MEDICAL
 
 
 
 
11.2.3
MERIL LIFE SCIENCES PVT. LTD.
 
 
 
 
11.2.4
GLOBUS MEDICAL
 
 
 
 
11.2.5
SAMYANG HOLDINGS CORPORATION
 
 
 
 
11.2.6
AROA BIOSURGERY LIMITED
 
 
 
 
11.2.7
MEYER-HAAKE GMBH
 
 
 
 
11.2.8
ADVANCED MEDICAL SOLUTIONS GROUP PLC
 
 
 
 
11.2.9
BIOCER ENTWICKLUNGS-GMBH
 
 
 
 
11.2.10
WILTROM
 
 
12
APPENDIX
 
 
 
404
 
12.1
DISCUSSION GUIDE
 
 
 
 
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
12.3
CUSTOMIZATION OPTIONS
 
 
 
 
12.4
RELATED REPORTS
 
 
 
 
12.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
BIOSURGERY MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
TABLE 2
STANDARD CURRENCY CONVERSION RATES
 
 
 
 
TABLE 3
BIOSURGERY MARKET: STUDY ASSUMPTIONS
 
 
 
 
TABLE 4
BIOSURGERY MARKET: RISK ANALYSIS
 
 
 
 
TABLE 5
IMPORT DATA FOR HS CODE 300610, BY COUNTRY, 2019–2024 (USD THOUSAND)
 
 
 
 
TABLE 6
EXPORT DATA FOR HS CODE 300610, BY COUNTRY, 2019–2024 (USD THOUSAND)
 
 
 
 
TABLE 7
BIOSURGERY MARKET: PORTER’S FIVE FORCES
 
 
 
 
TABLE 8
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE BIOSURGERY PRODUCTS
 
 
 
 
TABLE 9
KEY BUYING CRITERIA FOR BIOSURGERY PRODUCTS
 
 
 
 
TABLE 10
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 14
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 15
AVERAGE SELLING PRICE TREND OF BIOSURGERY PRODUCTS, BY KEY PLAYER, 2022–2024 (USD)
 
 
 
 
TABLE 16
AVERAGE SELLING PRICE TREND OF BIOSURGERY PRODUCTS, BY REGION, 2022–2024 (USD)
 
 
 
 
TABLE 17
BIOSURGERY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
 
 
 
 
TABLE 18
BIOSURGERY MARKET: UNMET NEEDS/END-USER EXPECTATIONS
 
 
 
 
TABLE 19
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 20
KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR BIOSURGERY PRODUCTS
 
 
 
 
TABLE 21
BIOSURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 22
BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 23
BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 24
MAJOR DEMINERALIZED BONE MATRIX PRODUCTS AVAILABLE IN MARKET
 
 
 
 
TABLE 25
DEMINERALIZED BONE MATRIX MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 26
MAJOR SYNTHETIC BONE GRAFTS AVAILABLE IN MARKET
 
 
 
 
TABLE 27
SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 28
MAJOR BONE MORPHOGENETIC PROTEINS AVAILABLE IN MARKET
 
 
 
 
TABLE 29
BONE MORPHOGENETIC PROTEINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 30
OTHER BONE-GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 32
BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
MAJOR FIBRIN-BASED SEALANTS & ADHESIVES AVAILABLE IN MARKET
 
 
 
 
TABLE 36
FIBRIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
MAJOR COLLAGEN BASED-SEALANTS & ADHESIVES AVAILABLE IN MARKET
 
 
 
 
TABLE 38
COLLEGEN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
MAJOR GELATIN BASED-SEALANTS & ADHESIVES AVAILABLE IN MARKET
 
 
 
 
TABLE 40
GELATIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
MAJOR ALBUMIN BASED-SEALANTS & ADHESIVES AVAILABLE IN MARKET
 
 
 
 
TABLE 42
ALBUMIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
OTHER NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
ANIMAL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
HUMAN BLOOD-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
MAJOR PRODUCTS PEG HYDROGEL-BASED SEALANTS & ADHESIVES AVAILABLE IN MARKET
 
 
 
 
TABLE 50
PEG HYROGEL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
MAJOR CYANOACRYLATE-BASED SEALANTS & ADHESIVES AVAILABLE IN MARKET
 
 
 
 
TABLE 52
CYANOACRYLATE-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
URETHANE-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
OTHER SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
BIOSURGERY MARKET FOR ADHESION BARRIERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 58
SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
MAJOR HYALURONIC ACID-BASED ADHESION BARRIERS AVAILABLE IN MARKET
 
 
 
 
TABLE 60
HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
MAJOR REGENERATED CELLULOSE-BASED ADHESION BARRIERS AVAILABLE IN MARKET
 
 
 
 
TABLE 62
REGENERATED CELLULOSE -BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
MAJOR PEG-BASED ADHESION BARRIERS AVAILABLE IN MARKET
 
 
 
 
TABLE 64
PEG-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
MAJOR COLLAGEN & PROTEIN ADHESION BARRIERS AVAILABLE IN MARKET
 
 
 
 
TABLE 68
COLLAGEN & PROTEIN ADHESION BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
MAJOR FIBRIN-BASED ADHESION BARRIERS AVAILABLE IN MARKET
 
 
 
 
TABLE 70
FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
MAJOR STAPLE-LINE REINFORCEMENT AGENTS AVAILABLE IN MARKET
 
 
 
 
TABLE 72
BIOSURGERY MARKET FOR STAPLE-LINE REINFORCEMENT AGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
BIOSURGERY MARKET FOR SOFT-TISSUE ATTCHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
BIOSURGERY MARKET FOR SOFT-TISSUE ATTCHMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
MAJOR SYNTHETIC MESHES AVAILABLE IN MARKET
 
 
 
 
TABLE 76
SYNTHETIC MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
MAJOR BIOLOGICAL MESHES AVAILABLE IN MARKET
 
 
 
 
TABLE 78
BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
ALLOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
XENOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
MAJOR HEMOSTATIC AGENTS AVAILABLE IN MARKET
 
 
 
 
TABLE 83
BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
MAJOR THROMBIN-BASED HEMOSTATIC AGENTS AVAILABLE IN MARKET
 
 
 
 
TABLE 86
THROMBIN-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
MAJOR OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS AVAILABLE IN MARKET
 
 
 
 
TABLE 88
OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
MAJOR COMBINATION HEMOSTATIC AGENTS AVAILABLE IN MARKET
 
 
 
 
TABLE 90
COMBINATION HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 92
BIOSURGERY MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
BIOSURGERY MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
BIOSURGERY MARKET FOR NEUROLOGICAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
BIOSURGERY MARKET FOR CARDIOVASCULAR SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 96
BIOSURGERY MARKET FOR RECONSTRUCTIVE SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
BIOSURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
BIOSURGERY MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
BIOSURGERY MARKET FOR THORACIC SURGERY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
BIOSURGERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
BIOSURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
BIOSURGERY MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
BIOSURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
BIOSURGERY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
BIOSURGERY MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 107
NORTH AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
NORTH AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
NORTH AMERICA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
NORTH AMERICA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
NORTH AMERICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
NORTH AMERICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
NORTH AMERICA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
NORTH AMERICA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
NORTH AMERICA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
NORTH AMERICA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
NORTH AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
NORTH AMERICA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
US: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
US: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
US: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
US: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
US: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
US: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
US: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
US: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
US: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
US: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
US: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
US: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
CANADA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
CANADA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
CANADA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
CANADA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
CANADA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
CANADA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
CANADA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
CANADA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
CANADA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
CANADA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
CANADA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
EUROPE: BIOSURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
EUROPE: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
EUROPE: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
EUROPE: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
EUROPE: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
EUROPE: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
EUROPE: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
EUROPE: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
EUROPE: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
EUROPE: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
EUROPE: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
EUROPE: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
GERMANY: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
GERMANY: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 167
GERMANY: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
GERMANY: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
GERMANY: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 170
GERMANY: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
GERMANY: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
GERMANY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
GERMANY: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 175
GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 176
GERMANY: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
GERMANY: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
GERMANY: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
UK: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
UK: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
UK: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
UK: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
UK: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 184
UK: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 185
UK: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 186
UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
UK: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 188
UK: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 190
UK: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
UK: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
UK: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 193
FRANCE: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 194
FRANCE: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
FRANCE: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
FRANCE: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
FRANCE: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
FRANCE: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
FRANCE: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
FRANCE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 202
FRANCE: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 203
FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
FRANCE: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
FRANCE: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
FRANCE: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
ITALY: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 208
ITALY: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
ITALY: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
ITALY: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 211
ITALY: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 212
ITALY: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 213
ITALY: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
ITALY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
ITALY: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
ITALY: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
ITALY: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 220
ITALY: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
SPAIN: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
SPAIN: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 223
SPAIN: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
SPAIN: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
SPAIN: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
SPAIN: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
SPAIN: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 229
SPAIN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
SPAIN: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
SPAIN: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
SPAIN: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
SPAIN: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
REST OF EUROPE: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 236
REST OF EUROPE: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 237
REST OF EUROPE: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
REST OF EUROPE: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
REST OF EUROPE: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
REST OF EUROPE: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
REST OF EUROPE: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
REST OF EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
REST OF EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 244
REST OF EUROPE: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 245
REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
REST OF EUROPE: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
REST OF EUROPE: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
REST OF EUROPE: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
ASIA PACIFIC: BIOSURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
ASIA PACIFIC: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
ASIA PACIFIC: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 252
ASIA PACIFIC: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
ASIA PACIFIC: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
ASIA PACIFIC: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
ASIA PACIFIC: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
ASIA PACIFIC: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
ASIA PACIFIC: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 260
ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
ASIA PACIFIC: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 262
ASIA PACIFIC: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
ASIA PACIFIC: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
CHINA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
CHINA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
CHINA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
CHINA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 268
CHINA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
CHINA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
CHINA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
CHINA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
CHINA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
CHINA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 276
CHINA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
CHINA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
INDIA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
INDIA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 280
INDIA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
INDIA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
INDIA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
INDIA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 284
INDIA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 285
INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 286
INDIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 287
INDIA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 288
INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 289
INDIA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 290
INDIA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 291
INDIA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 292
JAPAN: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 293
JAPAN: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 294
JAPAN: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 295
JAPAN: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 296
JAPAN: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 297
JAPAN: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 298
JAPAN: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 299
JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 300
JAPAN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 301
JAPAN: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 302
JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 303
JAPAN: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 304
JAPAN: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 305
JAPAN: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 306
SOUTH KOREA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 307
SOUTH KOREA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 308
SOUTH KOREA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 309
SOUTH KOREA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 310
SOUTH KOREA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 311
SOUTH KOREA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 312
SOUTH KOREA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 313
SOUTH KOREA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 314
SOUTH KOREA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 315
SOUTH KOREA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 316
SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 317
SOUTH KOREA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 318
SOUTH KOREA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 319
SOUTH KOREA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 320
AUSTRALIA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 321
AUSTRALIA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 322
AUSTRALIA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 323
AUSTRALIA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 324
AUSTRALIA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 325
AUSTRALIA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 326
AUSTRALIA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 327
AUSTRALIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 328
AUSTRALIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 329
AUSTRALIA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 330
AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 331
AUSTRALIA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 332
AUSTRALIA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 333
AUSTRALIA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 334
REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 335
REST OF ASIA PACIFIC: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 336
REST OF ASIA PACIFIC: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 337
REST OF ASIA PACIFIC: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 338
REST OF ASIA PACIFIC: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 339
REST OF ASIA PACIFIC: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 340
REST OF ASIA PACIFIC: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 341
REST OF ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 342
REST OF ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 343
REST OF ASIA PACIFIC: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 344
REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 345
REST OF ASIA PACIFIC: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 346
REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 347
REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 348
LATIN AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 349
LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 350
LATIN AMERICA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 351
LATIN AMERICA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 352
LATIN AMERICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 353
LATIN AMERICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 354
LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 355
LATIN AMERICA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 356
LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 357
LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 358
LATIN AMERICA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 359
LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 360
LATIN AMERICA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 361
LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 362
LATIN AMERICA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 363
BRAZIL: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 364
BRAZIL: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 365
BRAZIL: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 366
BRAZIL: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 367
BRAZIL: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 368
BRAZIL: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 369
BRAZIL: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 370
BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 371
BRAZIL: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 372
BRAZIL: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 373
BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 374
BRAZIL: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 375
BRAZIL: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 376
BRAZIL: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 377
MEXICO: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 378
MEXICO: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 379
MEXICO: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 380
MEXICO: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 381
MEXICO: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 382
MEXICO: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 383
MEXICO: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 384
MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 385
MEXICO: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 386
MEXICO: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 387
MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 388
MEXICO: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 389
MEXICO: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 390
MEXICO: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 391
REST OF LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 392
REST OF LATIN AMERICA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 393
REST OF LATIN AMERICA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 394
REST OF LATIN AMERICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 395
REST OF LATIN AMERICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 396
REST OF LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 397
REST OF LATIN AMERICA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 398
REST OF LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 399
REST OF LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 400
REST OF LATIN AMERICA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 401
REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 402
REST OF LATIN AMERICA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 403
REST OF LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 404
REST OF LATIN AMERICA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 405
MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 406
MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 407
MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 408
MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 409
MIDDLE EAST & AFRICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 410
MIDDLE EAST & AFRICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 411
MIDDLE EAST & AFRICA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 412
MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 413
MIDDLE EAST & AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 414
MIDDLE EAST & AFRICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 415
MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 416
MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 417
MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 418
MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 419
MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 420
GCC COUNTRIES: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 421
GCC COUNTRIES: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 422
GCC COUNTRIES: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 423
GCC COUNTRIES: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 424
GCC COUNTRIES: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 425
GCC COUNTRIES: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 426
GCC COUNTRIES: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 427
GCC COUNTRIES: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 428
GCC COUNTRIES: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 429
GCC COUNTRIES: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 430
GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 431
GCC COUNTRIES: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 432
GCC COUNTRIES: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 433
GCC COUNTRIES: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 434
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 435
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 436
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 437
REST OF MIDDLE EAST & AFRICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 438
REST OF MIDDLE EAST & AFRICA: NATURAL/BIOLOGICAL SURGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 439
REST OF MIDDLE EAST & AFRICA: SYNTHETIC & SEMI-SYNTHETIC SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 440
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 441
REST OF MIDDLE EAST & AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 442
REST OF MIDDLE EAST & AFRICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 443
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 444
REST OF MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 445
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 446
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 447
REST OF MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 448
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN BIOSURGERY MARKET
 
 
 
 
TABLE 449
BIOSURGERY MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 450
BIOSURGERY MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 451
BIOSURGERY MARKET: PRODUCT FOOTPRINT
 
 
 
 
TABLE 452
BIOSURGERY MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 453
BIOSURGERY MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 454
BIOSURGERY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
 
 
 
 
TABLE 455
BIOSURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
 
 
 
 
TABLE 456
BIOSURGERY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2025
 
 
 
 
TABLE 457
BIOSURGERY MARKET: DEALS, JANUARY 2022–JUNE 2025
 
 
 
 
TABLE 458
BAXTER: COMPANY OVERVIEW
 
 
 
 
TABLE 459
BAXTER: PRODUCTS OFFERED
 
 
 
 
TABLE 460
B BRAUN SE: COMPANY OVERVIEW
 
 
 
 
TABLE 461
B BRAUN SE: PRODUCTS OFFERED
 
 
 
 
TABLE 462
BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
 
 
 
 
TABLE 463
BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
 
 
 
 
TABLE 464
JOHNSON & JOHNSON: COMPANY OVERVIEW
 
 
 
 
TABLE 465
JOHNSON & JOHNSON: PRODUCTS OFFERED
 
 
 
 
TABLE 466
MEDTRONIC: COMPANY OVERVIEW
 
 
 
 
TABLE 467
MEDTRONIC: PRODUCTS OFFERED
 
 
 
 
TABLE 468
INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 469
INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 470
COMMONWEALTH SERUM LABORATORIES LIMITED (CSL): COMPANY OVERVIEW
 
 
 
 
TABLE 471
COMMONWEALTH SERUM LABORATORIES LIMITED (CSL): PRODUCTS OFFERED
 
 
 
 
TABLE 472
HEMOSTASIS, LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 473
HEMOSTASIS, LLC: PRODUCTS OFFERED
 
 
 
 
TABLE 474
PFIZER INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 475
PFIZER INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 476
STRYKER: COMPANY OVERVIEW
 
 
 
 
TABLE 477
STRYKER: PRODUCTS OFFERED
 
 
 
 
TABLE 478
ARTIVION, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 479
ARTIVION, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 480
ZIMMER BIOMET: COMPANY OVERVIEW
 
 
 
 
TABLE 481
ZIMMER BIOMET: PRODUCTS OFFERED
 
 
 
 
TABLE 482
ZIMMER BIOMET: DEALS, JANUARY 2022–JUNE 2025
 
 
 
 
TABLE 483
KUROS BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 484
KUROS BIOSCIENCES: PRODUCTS OFFERED
 
 
 
 
TABLE 485
KUROS BIOSCIENCES: PRODUCT APPROVALS, JANUARY 2021–JUNE 2025
 
 
 
 
TABLE 486
KUROS BIOSCIENCES: DEALS, JANUARY 2022–JUNE 2025
 
 
 
 
TABLE 487
ORTHOFIX MEDICAL INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 488
ORTHOFIX MEDICAL INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 489
ORTHOFIX MEDICAL INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
TABLE 490
ORTHOFIX MEDICAL INC.: DEALS, JANUARY 2022–JUNE 2025
 
 
 
 
TABLE 491
SMITH & NEPHEW: COMPANY OVERVIEW
 
 
 
 
TABLE 492
SMITH & NEPHEW: PRODUCTS OFFERED
 
 
 
 
TABLE 493
TISSUE REGENIX: COMPANY OVERVIEW
 
 
 
 
TABLE 494
BETATECH MEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 495
MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 496
GLOBUS MEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 497
SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 498
AROA BIOSURGERY LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 499
MEYER-HAAKE GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 500
ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW
 
 
 
 
TABLE 501
BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 502
WILTROM: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
BIOSURGERY MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
FIGURE 2
BIOSURGERY MARKET: YEARS CONSIDERED
 
 
 
 
FIGURE 3
BIOSURGERY MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 4
BIOSURGERY MARKET: KEY DATA FROM SECONDARY SOURCES
 
 
 
 
FIGURE 5
BIOSURGERY MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES)
 
 
 
 
FIGURE 6
BIOSURGERY MARKET: KEY DATA FROM PRIMARY SOURCES
 
 
 
 
FIGURE 7
BIOSURGERY MARKET: KEY INDUSTRY INSIGHTS
 
 
 
 
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 9
BIOSURGERY MARKET SIZE ESTIMATION (REVENUE SHARE ANALYSIS)
 
 
 
 
FIGURE 10
BIOSURGERY MARKET: TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
 
 
 
 
FIGURE 12
BIOSURGERY MARKET: CAGR PROJECTIONS
 
 
 
 
FIGURE 13
BIOSURGERY MARKET: DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 14
BIOSURGERY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
BIOSURGERY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
BIOSURGERY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
BIOSURGERY MARKET: REGIONAL SNAPSHOT
 
 
 
 
FIGURE 18
RISING SURGICAL VOLUMES AND INCREASING FOCUS ON MEDICAL TOURISM TO DRIVE MARKET
 
 
 
 
FIGURE 19
US AND HOSPITALS SEGMENT COMMANDED LARGEST NORTH AMERICAN MARKET SHARE IN 2024
 
 
 
 
FIGURE 20
INDIA TO WITNESS HIGHEST CAGR DURING STUDY PERIOD
 
 
 
 
FIGURE 21
ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
 
 
 
 
FIGURE 22
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
 
 
 
FIGURE 23
BIOSURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 24
BIOSURGERY MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 25
BIOSURGERY MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 26
BIOSURGERY MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 27
BIOSURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 28
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE BIOSURGERY PRODUCTS
 
 
 
 
FIGURE 29
KEY BUYING CRITERIA FOR BIOSURGERY PRODUCTS
 
 
 
 
FIGURE 30
CANADA: CLASS III MEDICAL DEVICE APPROVAL PROCESS
 
 
 
 
FIGURE 31
TOP 10 COMPANIES WITH HIGHEST NUMBER OF PATENTS APPLIED/PUBLISHED (JANUARY 2014–JUNE 2025)
 
 
 
 
FIGURE 32
TOP APPLICANT COUNTRIES/REGIONS FOR BIOSURGERY PATENTS (JANUARY 2014− MAY 2025)
 
 
 
 
FIGURE 33
ADJACENT MARKET ANALYSIS: ADHESION BARRIERS MARKET (MARKET OVERVIEW)
 
 
 
 
FIGURE 34
BIOSURGERY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
FIGURE 35
BIOSURGERY MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 (USD MILLION)
 
 
 
 
FIGURE 36
KEY FEATURES OF AI/GEN AI IN BIOSURGERY MARKET
 
 
 
 
FIGURE 37
BIOSURGERY MARKET: GEOGRAPHIC SNAPSHOT
 
 
 
 
FIGURE 38
NORTH AMERICA: BIOSURGERY MARKET SNAPSHOT
 
 
 
 
FIGURE 39
ASIA PACIFIC: BIOSURGERY MARKET SNAPSHOT
 
 
 
 
FIGURE 40
REVENUE ANALYSIS OF KEY PLAYERS IN BIOSURGERY MARKET (2020–2024)
 
 
 
 
FIGURE 41
MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOSURGERY MARKET (2024)
 
 
 
 
FIGURE 42
BIOSURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 43
BIOSURGERY MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 44
BIOSURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 45
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 46
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 47
BIOSURGERY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 48
BAXTER: COMPANY SNAPSHOT
 
 
 
 
FIGURE 49
B BRAUN SE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 50
BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
 
 
 
 
FIGURE 51
JOHNSON & JOHNSON: COMPANY SNAPSHOT
 
 
 
 
FIGURE 52
MEDTRONIC: COMPANY SNAPSHOT
 
 
 
 
FIGURE 53
INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 54
COMMONWEALTH SERUM LABORATORIES LIMITED (CSL): COMPANY SNAPSHOT
 
 
 
 
FIGURE 55
PFIZER INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 56
STRYKER: COMPANY SNAPSHOT
 
 
 
 
FIGURE 57
ARTIVION, INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 58
ZIMMER BIOMET: COMPANY SNAPSHOT
 
 
 
 
FIGURE 59
KUROS BIOSCIENCES: COMPANY SNAPSHOT
 
 
 
 
FIGURE 60
ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 61
SMITH & NEPHEW: COMPANY SNAPSHOT
 
 
 
 

Methodology

The study involved major activities in estimating the current market size for the biosurgery market. Exhaustive secondary research was done to collect information on the biosurgery industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Biosurgery market.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biosurgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biosurgery market. The primary sources from the demand side include ambulatory surgical centers, hospitals, Clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Biosurgery Market

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biosurgery market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biosurgery market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various biosurgery manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from biosurgery (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global biosurgery market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom-up Approach and Top-down Approach)

Biosurgery Market

Data Triangulation

After arriving at the global biosurgery market's overall size through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Biosurgery products are essential in surgical procedures, aiding in the repair of damaged tissues and bones. Surgeons utilize these products to stabilize skin, internal organs, and blood vessels, ensuring hemostasis and tissue integrity after injury or surgery. Key types include surgical sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents, all designed to enhance healing and prevent complications.

Stakeholders

  • Transfection products manufacturing companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Chemical Companies
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Research Institutes and Universities 
  • Venture Capitalists & Investors
  • Government Associations

Report Objectives

  • To define, describe, segment, and forecast the transfection technologies market by product type, method, application, end user, and region
  • To provide detailed information about the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the transfection technologies market in five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
  • To profile the key players in the transfection technologies market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments, such as product launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the transfection technologies market
  • To benchmark players within the transfection technologies market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share/rank

Frequently Asked Questions (FAQ)

Which are the top industry players in the global biosurgery market?

Key players include Johnson & Johnson Services, Inc. (US), Baxter (US), Medtronic (Ireland), Becton, Dickinson and Company (BD) (US), B. Braun SE (Germany), and Stryker (US).

What are some of the major drivers for this market?

The increasing volume of surgeries and prevalence of severe trauma injuries are driving R&D efforts, resulting in the launch of technologically advanced products that support market growth.

Which end users have been included in the global biosurgery market?

Hospitals, Clinics, Ambulatory Surgical Centers, and Other End Users.

Which type of biosurgery products held the largest market share in 2024?

The bone graft substitute segment held the largest market share in 2024.

Which region is lucrative for the biosurgery market?

The Asia Pacific region is projected to experience the highest CAGR during the forecast period.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Biosurgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Biosurgery Market

Edward

Oct, 2022

What are the latest technological trends in biosurgery products?.

Tyler

Oct, 2022

What are the latest innovations in Biosurgery Market?.

Matthew

Oct, 2022

Which region to focus more for business expansion in Biosurgery Market?.

DMCA.com Protection Status